Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 06 SEPTEMBER 2018

Brexit And The Pharmaceuticals Sector: The Key Issues

Reed Smith (Worldwide)
Explore more from Reed Smith (Worldwide)

The United Kingdom (UK) is scheduled to leave the European Union on 29 March 2019. Certain key aspects of the Brexit deal now seem to have been agreed upon

European UnionGovernment, Public Sector
Carolyn Pepper
Carolyn Pepper
Author LinkedIn connections

The United Kingdom (UK) is scheduled to leave the European Union on 29 March 2019. Certain key aspects of the Brexit deal now seem to have been agreed upon, including a 21 month "transitional period" after the UK's exit, but the full agreement has not yet been finalized and there is currently a risk of no deal being reached. The UK pharmaceuticals sector is a key industry seeking clarity, particularly on the following important areas:

  • Continued membership of the UK in the European Medicines Agency (EMA) regime. The EMA is the European Union (EU) body responsible for the regulation of medicines supplied in EU territories (currently situated in London; scheduled to relocate to Amsterdam next year). It is also responsible for the market authorization of pharmaceuticals across the EU and EEA-EFTA states. If the UK leaves the EMA regime on Brexit, the regulation and authorization process will likely become more costly and time-consuming because pharma companies may need

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

Budget Tracker (2026)

The Chancellor of the Exchequer faces the formidable challenge of delivering his first Budget amid economic headwinds, geopolitical instability, and a wave of ambitious government promises. With GDP growth forecast at just 1.1%, inflation at 3.4%, and public sector net borrowing exceeding £115 billion, can he balance fiscal responsibility with pledges to avoid raising Income Tax, National Insurance, or VAT while funding increased defence spending and social care reforms?
United KingdomGovernment, Public Sector
Travers Smith LLP
Travers Smith LLP
Article

Sanctions: Fortnightly Summary

The UK government has significantly expanded its sanctions framework targeting Russia, introducing measures against individuals and entities involved in military supply chains, energy sectors, cryptocurrency networks, and alleged human rights violations. These developments reflect an evolving enforcement landscape with new powers, increased scrutiny of sanctions evasion, and landmark legal clarifications affecting businesses operating in sanctioned jurisdictions.
European UnionGovernment, Public Sector
BCL Solicitors LLP
BCL Solicitors LLP
Article

Investing In Infrastructure: When Public Policy Meets Private Capital

Governments across the UK and Europe have announced ambitious infrastructure programmes they cannot fund alone, creating significant opportunities for private capital. As public authorities shift from subsidy-based models to regulatory reform, investors must navigate an increasingly complex web of concurrent regulatory regimes - from merger control and national security screening to data protection and PFI handback obligations - to successfully deploy capital in this evolving landscape.
European UnionGovernment, Public Sector
Macfarlanes LLP
Macfarlanes LLP
Article

Foreign Direct Investment (FDI) And National Security Screening

Angela Gregson of Weightmans and Sean Ryan of Whitney Moore compare Ireland's new foreign direct investment screening regime with the UK's established National Security and Investment Act, examining when notification is required, key procedural differences, and practical steps to navigate both frameworks. The analysis draws on recent annual reports to reveal how these regimes are operating in practice and what reforms are on the horizon.
United KingdomGovernment, Public Sector
Weightmans LLP
Weightmans LLP